Back to Search Start Over

A reference induced pluripotent stem cell line for large-scale collaborative studies

Authors :
Caroline B. Pantazis
Andrian Yang
Erika Lara
Justin A. McDonough
Cornelis Blauwendraat
Lirong Peng
Hideyuki Oguro
Jitendra Kanaujiya
Jizhong Zou
David Sebesta
Gretchen Pratt
Erin Cross
Jeffrey Blockwick
Philip Buxton
Lauren Kinner-Bibeau
Constance Medura
Christopher Tompkins
Stephen Hughes
Marianita Santiana
Faraz Faghri
Mike A. Nalls
Daniel Vitale
Shannon Ballard
Yue A. Qi
Daniel M. Ramos
Kailyn M. Anderson
Julia Stadler
Priyanka Narayan
Jason Papademetriou
Luke Reilly
Matthew P. Nelson
Sanya Aggarwal
Leah U. Rosen
Peter Kirwan
Venkat Pisupati
Steven L. Coon
Sonja W. Scholz
Theresa Priebe
Miriam Öttl
Jian Dong
Marieke Meijer
Lara J.M. Janssen
Vanessa S. Lourenco
Rik van der Kant
Dennis Crusius
Dominik Paquet
Ana-Caroline Raulin
Guojun Bu
Aaron Held
Brian J. Wainger
Rebecca M.C. Gabriele
Jackie M Casey
Selina Wray
Dad Abu-Bonsrah
Clare L. Parish
Melinda S. Beccari
Don W. Cleveland
Emmy Li
Indigo V.L. Rose
Martin Kampmann
Carles Calatayud Aristoy
Patrik Verstreken
Laurin Heinrich
Max Y. Chen
Birgitt Schüle
Dan Dou
Erika L.F. Holzbaur
Maria Clara Zanellati
Richa Basundra
Mohanish Deshmukh
Sarah Cohen
Richa Khanna
Malavika Raman
Zachary S. Nevin
Madeline Matia
Jonas Van Lent
Vincent Timmerman
Bruce R. Conklin
Katherine Johnson Chase
Ke Zhang
Salome Funes
Daryl A. Bosco
Lena Erlebach
Marc Welzer
Deborah Kronenberg-Versteeg
Guochang Lyu
Ernest Arenas
Elena Coccia
Lily Sarrafha
Tim Ahfeldt
John C. Marioni
William C. Skarnes
Mark R. Cookson
Michael E. Ward
Florian T. Merkle
Source :
bioRxiv
Publication Year :
2021

Abstract

Human induced pluripotent stem cell (iPSC) lines are a powerful tool for studying development and disease, but the considerable phenotypic variation between lines makes it challenging to replicate key findings and integrate data across research groups. To address this issue, we sub-cloned candidate iPSC lines and deeply characterised their genetic properties using whole genome sequencing, their genomic stability upon CRISPR/Cas9-based gene editing, and their phenotypic properties including differentiation to commonly-used cell types. These studies identified KOLF2.1J as an all-around well-performing iPSC line. We then shared KOLF2.1J with groups around the world who tested its performance in head-to-head comparisons with their own preferred iPSC lines across a diverse range of differentiation protocols and functional assays. On the strength of these findings, we have made KOLF2.1J and hundreds of its gene-edited derivative clones readily accessible to promote the standardization required for large-scale collaborative science in the stem cell field.SummaryThe authors of this collaborative study deeply characterized human induced pluripotent stem cell (iPSC) lines to rationally select a clonally-derived cell line that performs well across multiple modalities. KOLF2.1J was identified as a candidate reference cell line based on single-cell analysis of its gene expression in the pluripotent state, whole genome sequencing, genomic stability after highly efficient CRISPR-mediated gene editing, integrity of the p53 pathway, and the efficiency with which it differentiated into multiple target cell populations. Since it is deeply characterized and can be readily acquired, KOLF2.1J is an attractive reference cell line for groups working with iPSCs.Graphical abstract

Details

Database :
OpenAIRE
Journal :
bioRxiv
Accession number :
edsair.doi.dedup.....16be7beeb9661c1c36cbc5f9bea57195
Full Text :
https://doi.org/10.1101/2021.12.15.472643